Revenue segments as reported by the company.

Premium and service revenues

Premium tax

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Selling, general and administrative

Depreciation

Amortization of acquired intangible assets

Premium tax expense

Health insurer fee expense

Impairment

Legal settlement

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Centene

Centene Corp. operates as a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Managed Care and Specialty Services. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Centene exceeds earnings guidance, eyes growth in Marketplace products

Centene's Q4 2022 earnings call highlighted robust financial performance, successful execution of value-creation plans, and a focus on operational efficiency. While challenges in Medicare Advantage margins are anticipated, opportunities in the Marketplace business and cost-cutting initiatives offer avenues for growth. Strategic initiatives to address demographic shifts and enhance care relationships position Centene for future success.

Centene reports strong Q1 earnings, focuses on growth opportunities

Centene's Q1 performance reflects strength in financial results and a strategic outlook for future growth.
Despite challenges in Medicare profitability and Medicaid redeterminations, Centene remains focused on maximizing membership and maintaining high margins.
Opportunities in enhancing relationships, investing in infrastructure, and updating margin assumptions position Centene for long-term success.

Centene reports strong Q2 earnings, raises 2023 outlook amidst challenges

Centene's Q2 earnings call showcased robust financial performance, operational efficiencies, and strategic wins in Medicaid and Marketplace segments. While facing challenges in cost trends and Star ratings strategy, the company is well-positioned for growth through revenue expansion and value-creation initiatives. Opportunities for engagement with key stakeholders and successful outreach efforts present avenues for continued success.

Centene exceeds Q3 earnings expectations, eyes growth opportunities in 2024

Centene's Q3 2023 earnings call highlighted strong financial performance, progress in Medicaid redeterminations, and operational advancements. The company anticipates continued growth in adjusted EPS for 2023 and 2024, with a focus on margin expansion and operational efficiencies. Challenges include managing membership declines and addressing questions on business plans and cost implications.

Centene exceeds 2023 expectations, poised for growth in 2024

Centene's 2023 performance was strong, exceeding expectations and positioning the company for continued growth. Key initiatives in Medicaid, Medicare Advantage, and Marketplace are driving revenue growth and operational efficiency. Challenges in managing utilization trends and achieving target margins require ongoing attention.

Centene surpasses Q1 earnings expectations, eyes growth in Medicaid and Marketplace

Centene's Q1 performance exceeded expectations, showcasing strength in Medicaid and Marketplace segments.
While facing challenges in contract protests and operational clarity, the company's strategic focus on Medicare Advantage and growth opportunities remain key strengths.
With a robust financial outlook and ongoing initiatives for optimization, Centene is well-positioned for continued success in the healthcare market.
Investors can be optimistic about Centene's growth trajectory, supported by strong operational performance and strategic initiatives.

Centene reports robust Q2 earnings, eyes Medicaid rebound and Medicare growth

Centene's Q2 2024 earnings call highlighted strong performance, Medicaid challenges, and growth opportunities in Medicaid and Medicare markets. Leadership transitions and focus on program innovation are key areas of development for the company.

Centene surpasses Q3 earnings expectations, eyes growth amid challenges

Centene's Q3 performance exceeded expectations, driven by improvements in Medicaid and strong Medicare and Marketplace segments.
Despite challenges in Medicaid and competitive pressures, Centene remains confident in its future growth and operational enhancements.
The company's strategic focus on AI, margin expansion, and quality improvement positions it well for continued success and profitability.
Analyst inquiries and company responses highlighted key areas of focus and potential areas for improvement and growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, international operations, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corporation is a full-line managed services company which services both government sponsored and private insurance health care programs. It’s stock has rallied nearly 40% in the last 2 months primarily due to two factors: 1.

Making Sense Of The 40% Jump In Centene’s Stock Since Early October

CVS Health

CVS Health's (CVS) latest collaboration with Centene is set to expand its Medicaid and Medicare Advantage presence in Illinois.

CVS Health Set to Acquire Centene's IlliniCare Health Plan

Acquisitions, rising revenues, growing membership and solid capital position carve out a long-term growth story for Centene (CNC).

Why Should You Hold Centene (CNC) Stock in Your Portfolio?

CVS Health will buy Medicaid and Medicare Advantage lines of business owned by Centene in Illinois as part of a divestiture needed by Centene to win approval of its WellCare acquisition.

CVS To Buy Centene’s Divested Illinois Medicare Advantage Plan

Centene (CNC) reported earnings 30 days ago. What's next for the stock?

Why Is Centene (CNC) Up 22.9% Since Last Earnings Report?

Anthem

HCA Healthcare

Humana

Tenet Healthcare

Universal Health Services

UnitedHealth Group

Hospital stocks gain from a less-than-expected strict price transparency rule and health insurers' optimism on a likely rise in profitability from a low-cost plan.

Healthcare Stocks in Focus on Price Transparency Rule

Cigna

Hospital and managed care stocks surged Friday as Wall Street saw President Trump's medical price transparency rules as reason to buy health care stocks.

UnitedHealth, HCA Break Out As Health Care Stocks Jump For Trump Medical Price Transparency

Investors were smiling at the insurer’s solid third-quarter results.

Here’s Why Centene Jumped 22.7% in October

DuPont de Nemours

DXC Technology

F5 Networks

Kroger

Viacom

The November to January period historically offers the strongest stock market returns, and these stocks may be poised to ride that seasonal pattern.

7 Stocks Poised to Rise as Market Enters Best Stretch in 8 Decades

Centene (CNC) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.

Centene (CNC) Catches Eye: Stock Jumps 6.5%

Centene's (CNC) CEO Michael Neidorff on Q3 2019 Results - Earnings Call Transcript

Great revenue and earnings growth made investors happy with the health insurer's latest performance.

What You'll Want to Know About Centene's Terrific Q3 Results

Centene's (CNC) third-quarter earnings gain traction from higher revenues.

Centene's (CNC) Q3 Earnings and Revenues Beat Estimates

Centene's (CNC) third quarter earnings reflect growth on the back of higher revenues.

Centene's (CNC) Q3 Earnings and Revenue Beat Estimates

Centene CNC, -2.37% , the health insurer, said third-quarter net income rose to $95 million, or 23 cents a share, from $19 million, or 5 cents a share, with revenue climbing to $18.98 billion from $16.18 billion on growth from the Health Insurance Marketplace business.

Centene reports profit growth that edges past consensus

Walgreens

Walgreens Boots Alliance, Centene and the pharmacy benefit manager RxAdvance are launching a cloud-based pharmacy management platform.

Walgreens Partners With Centene And AdvanceRx On Cloud PBM Deal

Centene's (CNC) third-quarter earnings are likely to have grown on the back of solid revenues.

What's in the Cards for Centene's (CNC) Earnings in Q3?

Centene (CNC) closed at $45.54 in the latest trading session, marking a +0.73% move from the prior day.

Centene (CNC) Gains As Market Dips: What You Should Know

Centene's (CNC) provider-led North Carolina subsidiary clinches Medicaid contract to provide services in additional areas.

Centene's Carolina Complete Health Wins Medicaid Contract

Centene (CNC) closed the most recent trading day at $42.73, moving -0.05% from the previous trading session.

Centene (CNC) Stock Moves -0.05%: What You Should Know

Carnival

FedEx

Twenty-First Century Fox

Altria

According to GuruFocus’ list of 52-week lows, these guru stocks have reached their 52-week lows.

52-Week Company Lows (Sep 30)

Centene (CNC) closed at $46.45 in the latest trading session, marking a +0.98% move from the prior day.

Centene (CNC) Stock Moves 0.98%: What You Should Know

Centene (CNC) could produce exceptional returns because of its solid growth attributes.

3 Reasons Growth Investors Will Love Centene (CNC)

Banking on a rising revenue base and an inorganic growth strategy, Centene (CNC) holds enough potential to reap benefits for investors.

Why Should You Retain Centene (CNC) Stock in Your Portfolio?

Centene's (CNC) subsidiary Health Net extends collaboration with Canopy Health to cater wider reach to its CaIPERS members.

News for Centene Stock (CNC)